Diagnostics and analysis of SARS-CoV-2: current status, recent
Por um escritor misterioso
Descrição
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study - The Lancet
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives - Chemical Science (RSC Publishing)
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry - The Lancet Oncology
An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection, Cell & Bioscience
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022
Diagnostics, Free Full-Text
COVID-19 - Wikipedia
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission - The Lancet Regional Health – Europe
de
por adulto (o preço varia de acordo com o tamanho do grupo)
